Glaxo plant with Legionnaires' bacteria is quiet for second day

All was quiet Wednesday at a GlaxoSmithKline pharmaceutical plant that was shut down after the drug maker discovered the bacteria that cause potentially fatal Legionnaires' disease in a cooling tower at the site.

Only a handful of cars could be seen in the parking lots outside the about 25 miles east of Raleigh where and other inhalable products are produced.

People can contract Legionnaires' disease when they inhale water vapor or mist containing the bacteria, the Centers for Disease Control and Prevention said. It does not spread from person to person, the agency said.

The cooling tower "does not come into contact with product manufactured at the facility," GlaxoSmithKline said late Tuesday.

Glaxo spokeswomen have not responded to questions about whether there was any risk of indoor exposure to employees or medicines from water droplets that could carry the . The company hasn't described what type of work was conducted at the shuttered location, how many people worked there, or whether there was any potential for contamination of medicines.

A U.S. Food and Drug Administration spokesman said Wednesday the drug safety regulator was still looking into the details and referred questions to GlaxoSmithKline.

No cases of Legionnaires' disease linked to the Glaxo plant have been reported, North Carolina health officials said Wednesday.

The plant produces inhaled drugs like Advair, a drug for asthma, and contracts with other pharmaceutical companies to produce their drugs.

Legionella bacteria found in cooling tanks in the Bronx section of New York City caused 12 Legionnaires' disease deaths this summer.

Most people who are exposed to the bacteria do not become ill, but about 8,000 to 18,000 Americans are hospitalized with the disease annually, the CDC said.

Explore further

Drugmaker Glaxo shuts down plant over Legionnaires' bacteria

© 2015 The Associated Press. All rights reserved.

Citation: Glaxo plant with Legionnaires' bacteria is quiet for second day (2015, August 12) retrieved 27 February 2020 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments